NDC 73377-036 - Telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-036
- Package NDCs from labels
- 73377-036-01, 73377-036-02, 73377-036-03, 73377-036-04, 73377-036-05, 73377-036-06, 73377-036-07, 73377-036-08, 73377-036-09
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Telmisartan - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-03-24 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-036-01 | Telmisartan | 250 g in 1 JAR | POWDER | 250 | 11 | |
| 73377-036-02 | Telmisartan | 50 g in 1 JAR | POWDER | 50 | 11 | |
| 73377-036-03 | Telmisartan | 42 g in 1 JAR | POWDER | 42 | 11 | |
| 73377-036-04 | Telmisartan | 1000 g in 1 JAR | POWDER | 1000 | 11 | |
| 73377-036-05 | Telmisartan | 100 g in 1 JAR | POWDER | 100 | 11 | |
| 73377-036-06 | Telmisartan | 950 g in 1 JAR | POWDER | 950 | 11 | |
| 73377-036-07 | Telmisartan | 5000 g in 1 JAR | POWDER | 5000 | 11 | |
| 73377-036-08 | Telmisartan | 46 g in 1 JAR | POWDER | 46 | 11 | |
| 73377-036-09 | Telmisartan | 85 g in 1 JAR | POWDER | 85 | 11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | Amneal Pharmaceuticals LLC | 20a60231-64f0-4751-aa81-6c0e64334179 | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Modavar Pharmaceuticals LLC | a075633a-2a2a-4e88-8ede-b49a3920a16c | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | A-S Medication Solutions | 509cd338-24db-41d1-a115-9dc999170717 | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Cadila Pharmaceuticals Limited | 353fcb30-2fa7-4ff1-8a18-26f3ec279d00 | 2023-08-02 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Amneal Pharmaceuticals of New York LLC | bf2dca37-ce9c-40e4-8ad6-b8186aa7fed1 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Mylan Pharmaceuticals Inc. | c3658bc8-1524-43db-930e-66f9ac01b808 | 2023-03-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Proficient Rx LP | 593a53a4-91bc-4e4a-aeff-08fc2efe3dd4 | 2020-06-01 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Mylan Pharmaceuticals Inc. | ca60a4d5-ace7-4889-94ee-e2265fd63811 | 2018-11-14 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.